| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2012-Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo | 1 | T | 1 Platinum/Etoposide + Atezo Induction + Maintenance | 189 | 57 | 15 | 7 | 2 | 0 | 0 | 06/28/2022 | 263 | 76 |
| 2 Platinum/Etoposide + Atezo Induction | 53 | 19 | 9 | 3 | 0 | 0 | ||||||||
| 3 Platinum/Etoposide Only | 57 | 22 | 14 | 8 | 0 | 0 | ||||||||
| 167 | 56 | 30 | 13 | 0 | 0 | |||||||||
| SN2426-cSCC, IC Met/Inop, Amivantamab v Cetuximab | 1 | Y | 1 Amivantamab and hyaluronidase (Safety Run-in) | 86 | 9 | 9 | 9 | 4 | 2 | 1 | 03/23/2026 | 112 | 29 | |
| 9 | 9 | 9 | 4 | 2 | 1 | |||||||||
| 21CTP.HN01-HN, Recur/Met, Amivantamab + Chemo | 1 | Y | 1 Amivantamab + Carboplatin + Paclitaxel | 50 | 8 | 8 | 8 | 5 | 2 | 0 | 03/25/2026 | |||
| 8 | 8 | 8 | 5 | 2 | 0 | |||||||||
| Yes | A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib | 0 | E | Total Registrations | 53 | 3 | 0 | 0 | 0 | 0 | 02/22/2016 | 279 | 81 | |
| 53 | 3 | 0 | 0 | 0 | 0 | |||||||||
| 1 | E | Total Registrations | 9 | 1 | 0 | 0 | 0 | 0 | 02/22/2016 | |||||
| 9 | 1 | 0 | 0 | 0 | 0 | |||||||||
| No | AGCT1531-Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult | 1 | E | Total Registrations | 5 | 2 | 1 | 0 | 0 | 0 | 10/07/2021 | 220 | 113 | |
| 5 | 2 | 1 | 0 | 0 | 0 | |||||||||
| AGCT1532-Inter/Poor Met GCTs, Accel v Std BEP Chemo | 1 | T | Total Registrations | 5 | 0 | 0 | 0 | 0 | 0 | 12/13/2019 | 212 | 91 | ||
| 5 | 0 | 0 | 0 | 0 | 0 | |||||||||
| EA7211-Sarc, Hi-Risk RetroPeritoneal, Neo+Sur | 1 | E | Total Registrations | 2 | 2 | 2 | 0 | 0 | 0 | 03/24/2026 | 38 | 9 | ||
| 2 | 2 | 2 | 0 | 0 | 0 | |||||||||
| EAY191-ComboMATCH | 1 | E | Total Registrations | 22 | 4 | 1 | 1 | 0 | 0 | 08/03/2023 | 322 | 118 | ||
| 22 | 4 | 1 | 1 | 0 | 0 | |||||||||
| Study | Registration/Phase | Open Date | # of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|
| S2505 Sarcoma, Stg II-IIIB, Surg + Short vs Std RT | 1 Randomization | 06-Jul-26 | 24 | 13 |
| AGCT1531 Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult | 2 Late Randomization Callback | 08-May-17 | 220 | 113 |
| EAY191 ComboMATCH | 2 Re-Screening | 06-Mar-23 | 322 | 118 |